Considerable insider selling last year and no insider transa...
Considerable insider selling last year and no insider transactions over the recent three months raise concern. Despite insiders owning 5.7%, CARsgen Therapeutics Holdings may not be the best investment choice.
Insiders Could Have Profited By Holding Onto CARsgen Therapeutics Holdings Shares Despite 23% Drop
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment